Trials / Completed
CompletedNCT05942365
A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam
A Phase 1, Open-Label, Two-Period，Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is a single-center, open label phase I clinical study to characterize the DDIs potential of ZSP1273 With Warfarin and Midazolam in Chinese healthy participants. This study also aims to evaluate the safety and tolerability of ZSP1273 in the presence of Warfarin and Midazolam.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZSP1273 | Drug Warfarin oral Drug midazolam oral |
Timeline
- Start date
- 2023-06-25
- Primary completion
- 2023-07-21
- Completion
- 2023-08-04
- First posted
- 2023-07-12
- Last updated
- 2023-12-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05942365. Inclusion in this directory is not an endorsement.